Ashoka University has appointed Professor Rishikesha T. Krishnan as its next Vice-Chancellor, effective August 1, 2026. A distinguished sch...

SpaceX's bold Mars vision faces scientific doubts. Experts highlight engineering challenges and human biology unknowns. Colonizing Mars pre...

Intel unveiled new AI-focused technologies, strategic collaborations, and next-generation processors at Computex 2026. The company announce...

Foreign portfolio investors offloaded Indian equities worth a net Rs 20,637 crore on Friday, marking one of the sharpest single-day selloff...

Artificial intelligence is increasingly being used to process complex genetic data, enabling new approaches in biological research. This sh...

A recent hantavirus outbreak on a cruise ship echoes past pandemic scares. Experts warn Disease X, a future unknown pathogen, is a near cer...

The Bengaluru-based firm said the new vehicle will invest between $500,000 and $3 million in IP-led firms across these sectors. The launch ...

Global index provider MSCI has announced significant changes to its indices. Federal Bank, Indian Bank, Multi Commodity Exchange of India, ...

In a significant move for medical innovation, Impetis Biosciences, a subsidiary of Tata group, has teamed up with Vyome Holdings from the U...

MSCI’s May 2026 index rejig kept India’s overall representation in the MSCI Standard Index unchanged at 165 stocks, even as four companies,...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

Odyssey Therapeutics debuted on Nasdaq with an 11.1% surge, reaching a $899.9 million valuation. The autoimmune disease specialist successf...

Extinct animals coming back: Scientists are pursuing de-extinction, aiming to bring back species like the woolly mammoth and bluebuck. The ...

Shares of Anthem BioSciences rose after Citi initiated coverage with a Buy rating and a target price of ₹870, implying over 20% upside. Ana...

Set up by ex-Biocon executive Ajay Bharadwaj, Rs.1200-crore Anthem Biosciences competes with Biocon owned Syngene International and Hyderab...

Vanta Bio is into offering toxicology evaluation services for pharmaceutical, biotech, food supplements and feed additives industries.

The Hyderabad-based firm and Onconova have entered into a JV to develop new drugs for cancer, GVK Biosciences said in a statement.